Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial (Q46320389)

21 December 2017

title

Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial (English)

1 reference

21 December 2017

multicenter clinical trial

1 reference

1 reference

1 reference

Mats Engström

1

1 reference

21 December 2017

Thomas Berg

2

1 reference

21 December 2017

Anna Stjernquist-Desatnik

3

1 reference

21 December 2017

Sara Axelsson

4

1 reference

21 December 2017

Anne Pitkäranta

5

1 reference

21 December 2017

Malou Hultcrantz

6

1 reference

21 December 2017

Mervi Kanerva

7

1 reference

21 December 2017

Per Hanner

8

1 reference

21 December 2017

Lars Jonsson

9

1 reference

21 December 2017

publication date

10 October 2008

1 reference

21 December 2017

published in

Lancet Neurology

1 reference

21 December 2017

volume

7

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

993-1000

1 reference

21 December 2017

Facial nerve enhancement in Bell's palsy demonstrated by different gadolinium-enhanced magnetic resonance imaging techniques

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Total intratemporal exposure of the facial nerve. Pathologic findings in Bell's palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Gadolinium-enhanced magnetic resonance imaging in Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Herpes Simplex Virus in Idiopathic Facial Paralysis (Bell Palsy)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Herpes-simplex virus as a cause of Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Corticosteroids for Bell's palsy (idiopathic facial paralysis)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Influence of early high-dose steroid treatment on Bell's palsy evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

The use of steroids in Bell's palsy: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Cortisone treatment of Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Corticosteroid treatment of childhood Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Facial nerve grading system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Early treatment with prednisolone or acyclovir in Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Detection of herpes simplex and varicella-zoster viruses in patients with Bell's palsy by the polymerase chain reaction technique.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

Sunnybrook and House-Brackmann Facial Grading Systems: intrarater repeatability and interrater agreement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970221-7

7 January 2021

10.1016/S1474-4422(08)70221-7

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18849193

1 reference

21 December 2017